Trial intelligence / Profile preview

Chlorhexidine versus povidone-iodine vaginal cleansing to prevent post-caesarean endometritis

PACTR202308561344907Completed

Sponsor
Nasiru Ibrahim Orisankoko
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in endometritis and postpartum infection comparing 4% chlorhexidine vaginal cleansing with 10% povidone-iodine vaginal cleansing (2 arms). Primary endpoint: Incidence of endometritis. Started Feb 2023; status: completed.

02

Drugs

chlorhexidinepovidone-iodine
03

Conditions

endometritispostpartum infection

Beyond the preview

Go deeper on PACTR202308561344907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202308561344907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call